APO Research
Talk to an analyst

APO RESEARCH · REPORT

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8)

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is a nitrogen-containing chemical substance or reagent identified by its named structure.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Functional groups, isomer identity, salt or free-base form, assay and impurity profile distinguish the material. Product-specific compatibility and handling must come from the relevant specification and documentation.

The commercial boundary

Use the selected edition’s stated product level, geography, years and measurement basis. Materials, components, finished systems and services are separate commercial boundaries unless that edition explicitly combines them.

Which identity, supplied form and impurity specification are required?

Functional groups, isomer identity, salt or free-base form, assay and impurity profile distinguish the material. Product-specific compatibility and handling must come from the relevant specification and documentation.

Selected research

Industry Research

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Research Report 2026

22 December 2025124 pages

Choose your research edition.

Industry Research3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market in revenue (US$ million) and, where applicable, sales volume (Kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Kg) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8).

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market by Company

Ningbo Innopharmchem

Manus Aktteva Biopharma

Hefei Home Sunshine Pharmaceutical

Nantong Zandery BioTechnology

Changzhou An Peng Chemical

Changzhou uniringchem

Huateng Pharmaceuticals

Shanghai Send Pharmaceutical

Pharmaffiliates Analytics & Synthetics

Biosynth Carbosynth

ChemScene

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Purity

97% Purity

98% Purity

Others

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Application

Pharmaceutical Intermediates

Organic Synthesis

3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Purity (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Manufacturers (Kg) & (2021-2026) Table 6. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Manufacturers Table 7. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Manufacturers (2021-2026) Table 9. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers, Product Type & Application Table 13. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Ningbo Innopharmchem Company Information Table 18. Ningbo Innopharmchem Business Overview Table 19. Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 20. Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 21. Ningbo Innopharmchem Recent Development Table 22. Manus Aktteva Biopharma Company Information Table 23. Manus Aktteva Biopharma Business Overview Table 24. Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 25. Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 26. Manus Aktteva Biopharma Recent Development Table 27. Hefei Home Sunshine Pharmaceutical Company Information Table 28. Hefei Home Sunshine Pharmaceutical Business Overview Table 29. Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 30. Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 31. Hefei Home Sunshine Pharmaceutical Recent Development Table 32. Nantong Zandery BioTechnology Company Information Table 33. Nantong Zandery BioTechnology Business Overview Table 34. Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 35. Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 36. Nantong Zandery BioTechnology Recent Development Table 37. Changzhou An Peng Chemical Company Information Table 38. Changzhou An Peng Chemical Business Overview Table 39. Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 40. Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 41. Changzhou An Peng Chemical Recent Development Table 42. Changzhou uniringchem Company Information Table 43. Changzhou uniringchem Business Overview Table 44. Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 45. Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 46. Changzhou uniringchem Recent Development Table 47. Huateng Pharmaceuticals Company Information Table 48. Huateng Pharmaceuticals Business Overview Table 49. Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 50. Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 51. Huateng Pharmaceuticals Recent Development Table 52. Shanghai Send Pharmaceutical Company Information Table 53. Shanghai Send Pharmaceutical Business Overview Table 54. Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 55. Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 56. Shanghai Send Pharmaceutical Recent Development Table 57. Pharmaffiliates Analytics & Synthetics Company Information Table 58. Pharmaffiliates Analytics & Synthetics Business Overview Table 59. Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 60. Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 61. Pharmaffiliates Analytics & Synthetics Recent Development Table 62. Biosynth Carbosynth Company Information Table 63. Biosynth Carbosynth Business Overview Table 64. Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 65. Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 66. Biosynth Carbosynth Recent Development Table 67. ChemScene Company Information Table 68. ChemScene Business Overview Table 69. ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 70. ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Portfolio Table 71. ChemScene Recent Development Table 72. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Table 73. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region (2021-2026) & (Kg) Table 74. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Region (2021-2026) Table 75. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Forecast by Region (2027-2032) & (Kg) Table 76. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share Forecast by Region (2027-2032) Table 77. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region (2021-2026) & (US$ Million) Table 79. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Region (2021-2026) Table 80. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Forecast by Region (2027-2032) & (US$ Million) Table 81. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (US$/Kg) by Region (2021-2026) Table 82. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (US$/Kg) by Region (2027-2032) Table 83. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Table 84. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2021-2026) & (Kg) Table 85. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Region (2021-2026) Table 86. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Forecasted Consumption by Region (2027-2032) & (Kg) Table 87. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Forecasted Consumption Market Share by Region (2027-2032) Table 88. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 89. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 90. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 91. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 92. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 93. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 94. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 95. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 96. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 97. South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 98. South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2026) & (Kg) Table 99. South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2027-2032) & (Kg) Table 100. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Purity (2021-2026) & (Kg) Table 101. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Purity (2027-2032) & (Kg) Table 102. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Purity (2021-2026) Table 103. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Purity (2027-2032) Table 104. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Purity (2021-2026) & (US$ Million) Table 105. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Purity (2027-2032) & (US$ Million) Table 106. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Purity (2021-2026) Table 107. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Purity (2027-2032) Table 108. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Purity (2021-2026) & (US$/Kg) Table 109. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Purity (2027-2032) & (US$/Kg) Table 110. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021-2026) & (Kg) Table 111. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2027-2032) & (Kg) Table 112. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2026) Table 113. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2027-2032) Table 114. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021-2026) & (US$ Million) Table 115. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2027-2032) & (US$ Million) Table 116. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2021-2026) Table 117. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2027-2032) Table 118. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Application (2021-2026) & (US$/Kg) Table 119. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Application (2027-2032) & (US$/Kg) Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Distributors List Table 123. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Customers List Table 124. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Trends Table 125. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Drivers Table 126. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Restraints Table 127. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Product Image Figure 5. Market Value Comparison by Purity (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. 97% Purity Product Image Figure 7. 98% Purity Product Image Figure 8. Others Product Image Figure 9. Pharmaceutical Intermediates Product Image Figure 10. Organic Synthesis Product Image Figure 11. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (2021-2032) & (US$ Million) Figure 13. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity (2021-2032) & (Kg) Figure 14. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production (2021-2032) & (Kg) Figure 15. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price (US$/Kg) & (2021-2032) Figure 16. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Manufacturers, Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Players Market Share by Production Value in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Figure 20. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 21. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million) Growth Rate (2021-2032) Figure 24. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million) Growth Rate (2021-2032) Figure 25. China 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Japan 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Comparison by Region: 2021 VS 2025 VS 2032 (Kg) Figure 28. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 30. North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 31. United States 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 32. United States 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 33. Canada 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 34. Mexico 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 35. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 36. Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 37. Germany 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 38. France 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 39. U.K. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 40. Italy 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 41. Russia 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 42. Spain 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 43. Netherlands 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 44. Switzerland 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 45. Sweden 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 46. Poland 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 47. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 48. Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 49. China 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 50. Japan 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 51. South Korea 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 52. India 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 53. Australia 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 54. Taiwan 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 55. Southeast Asia 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 56. South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 57. South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Market Share by Country (2021-2032) Figure 58. Brazil 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 59. Argentina 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 60. Chile 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 61. Turkey 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 62. GCC Countries 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption and Growth Rate (2021-2032) & (Kg) Figure 63. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Purity (2021-2032) Figure 64. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Purity (2021-2032) Figure 65. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price (US$/Kg) by Purity (2021-2032) Figure 66. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2032) Figure 67. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2021-2032) Figure 68. Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price (US$/Kg) by Application (2021-2032) Figure 69. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Value Chain Figure 70. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Opportunities and Challenges

Scope & coverage.

Types
  • 97% Purity
  • 98% Purity
  • Others
Applications
  • Pharmaceutical Intermediates
  • Organic Synthesis
Companies covered
  • Ningbo Innopharmchem
  • Manus Aktteva Biopharma
  • Hefei Home Sunshine Pharmaceutical
  • Nantong Zandery BioTechnology
  • Changzhou An Peng Chemical
  • Changzhou uniringchem
  • Huateng Pharmaceuticals
  • Shanghai Send Pharmaceutical
  • Pharmaffiliates Analytics & Synthetics
  • Biosynth Carbosynth
  • ChemScene

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by Purity
  3. 2.2.1 Market Value Comparison by Purity (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 97% Purity
  5. 2.2.3 98% Purity
  6. 2.2.4 Others
  7. 2.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  9. 2.3.2 Pharmaceutical Intermediates
  10. 2.3.3 Organic Synthesis
  11. 2.4 Global Market Growth Prospects
  12. 2.4.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
  13. 2.4.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity Estimates and Forecasts (2021-2032)
  14. 2.4.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Estimates and Forecasts (2021-2032)
  15. 2.4.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Manufacturers (2021-2026)
  2. 3.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Manufacturers (2021-2026)
  3. 3.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers, Product Type & Application
  7. 3.7 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Manufacturers Established Date
  8. 3.8 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Ningbo Innopharmchem
  2. 4.1.1 Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  3. 4.1.2 Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  4. 4.1.3 Ningbo Innopharmchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Ningbo Innopharmchem Product Portfolio
  6. 4.1.5 Ningbo Innopharmchem Recent Developments
  7. 4.2 Manus Aktteva Biopharma
  8. 4.2.1 Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  9. 4.2.2 Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  10. 4.2.3 Manus Aktteva Biopharma 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Manus Aktteva Biopharma Product Portfolio
  12. 4.2.5 Manus Aktteva Biopharma Recent Developments
  13. 4.3 Hefei Home Sunshine Pharmaceutical
  14. 4.3.1 Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  15. 4.3.2 Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  16. 4.3.3 Hefei Home Sunshine Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Hefei Home Sunshine Pharmaceutical Product Portfolio
  18. 4.3.5 Hefei Home Sunshine Pharmaceutical Recent Developments
  19. 4.4 Nantong Zandery BioTechnology
  20. 4.4.1 Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  21. 4.4.2 Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  22. 4.4.3 Nantong Zandery BioTechnology 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Nantong Zandery BioTechnology Product Portfolio
  24. 4.4.5 Nantong Zandery BioTechnology Recent Developments
  25. 4.5 Changzhou An Peng Chemical
  26. 4.5.1 Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  27. 4.5.2 Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  28. 4.5.3 Changzhou An Peng Chemical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Changzhou An Peng Chemical Product Portfolio
  30. 4.5.5 Changzhou An Peng Chemical Recent Developments
  31. 4.6 Changzhou uniringchem
  32. 4.6.1 Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  33. 4.6.2 Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  34. 4.6.3 Changzhou uniringchem 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Changzhou uniringchem Product Portfolio
  36. 4.6.5 Changzhou uniringchem Recent Developments
  37. 4.7 Huateng Pharmaceuticals
  38. 4.7.1 Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  39. 4.7.2 Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  40. 4.7.3 Huateng Pharmaceuticals 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Huateng Pharmaceuticals Product Portfolio
  42. 4.7.5 Huateng Pharmaceuticals Recent Developments
  43. 4.8 Shanghai Send Pharmaceutical
  44. 4.8.1 Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  45. 4.8.2 Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  46. 4.8.3 Shanghai Send Pharmaceutical 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Shanghai Send Pharmaceutical Product Portfolio
  48. 4.8.5 Shanghai Send Pharmaceutical Recent Developments
  49. 4.9 Pharmaffiliates Analytics & Synthetics
  50. 4.9.1 Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  51. 4.9.2 Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  52. 4.9.3 Pharmaffiliates Analytics & Synthetics 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Pharmaffiliates Analytics & Synthetics Product Portfolio
  54. 4.9.5 Pharmaffiliates Analytics & Synthetics Recent Developments
  55. 4.10 Biosynth Carbosynth
  56. 4.10.1 Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  57. 4.10.2 Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  58. 4.10.3 Biosynth Carbosynth 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Biosynth Carbosynth Product Portfolio
  60. 4.10.5 Biosynth Carbosynth Recent Developments
  61. 4.11 ChemScene
  62. 4.11.1 ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Company Information
  63. 4.11.2 ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Business Overview
  64. 4.11.3 ChemScene 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 ChemScene Product Portfolio
  66. 4.11.5 ChemScene Recent Developments
5 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region
  1. 5.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021-2032
  3. 5.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Region: 2021-2026
  4. 5.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Forecast by Region (2027-2032)
  5. 5.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region: 2021-2032
  7. 5.4.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Region: 2021-2026
  8. 5.4.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Forecast by Region (2027-2032)
  9. 5.5 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Market Price Analysis by Region (2021-2026)
  10. 5.6 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production and Value, YOY Growth
  11. 5.6.1 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Estimates and Forecasts (2021-2032)
6 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region
  1. 6.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region (2021-2032)
  3. 6.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Region: 2021-2026
  4. 6.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Purity
  1. 7.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Purity (2021-2032)
  2. 7.1.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Purity (2021-2032) & (Kg)
  3. 7.1.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Purity (2021-2032)
  4. 7.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Purity (2021-2032)
  5. 7.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Purity (2021-2032) & (US$ Million)
  6. 7.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Purity (2021-2032)
  7. 7.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Purity (2021-2032)
8 Segment by Application
  1. 8.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021-2032)
  2. 8.1.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production by Application (2021-2032) & (Kg)
  3. 8.1.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Market Share by Application (2021-2032)
  4. 8.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021-2032)
  5. 8.2.1 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Value Market Share by Application (2021-2032)
  7. 8.3 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Value Chain Analysis
  2. 9.1.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Production Mode & Process
  5. 9.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Distributors
  8. 9.2.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Customers
10 Global 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Analyzing Market Dynamics
  1. 10.1 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Trends
  2. 10.2 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Drivers
  3. 10.3 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Opportunities and Challenges
  4. 10.4 3-Iodo-1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (Cas# 151266-23-8) Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst